Nonpeptide endothelin antagonists in clinical development

被引:22
|
作者
Wu, CD [1 ]
Decker, ER [1 ]
Holland, GW [1 ]
Brown, PM [1 ]
Stavros, FD [1 ]
Brock, TA [1 ]
Dixon, RAF [1 ]
机构
[1] Texas Biotechnol Corp, Houston, TX 77030 USA
来源
DRUGS OF TODAY | 2001年 / 37卷 / 07期
关键词
D O I
10.1358/dot.2001.37.7.844187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:441 / 453
页数:13
相关论文
共 50 条
  • [21] EFFECT OF DIFFERENT ENDOTHELIN RECEPTOR ANTAGONISTS AND OF THE NOVEL NONPEPTIDE ANTAGONIST RO 46-2005 ON ENDOTHELIN LEVELS IN RAT PLASMA
    LOFFLER, BM
    BREU, V
    CLOZEL, M
    FEBS LETTERS, 1993, 333 (1-2) : 108 - 110
  • [22] Nonpeptide endothelin receptor antagonists .6. Pharmacological characterization of SE 217242, a potent and highly bioavailable endothelin receptor antagonist
    Ohlstein, EH
    Nambi, P
    Lago, A
    Hay, DWP
    Beck, G
    Fong, KL
    Eddy, EP
    Smith, P
    Ellens, H
    Elliott, JD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 276 (02): : 609 - 615
  • [23] DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF POTENT NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS
    LAGO, MA
    COUSINS, RD
    GAO, AM
    LEBER, JD
    PEISHOFF, CE
    OHLSTEIN, EH
    ELLIOTT, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 143 - MEDI
  • [24] SYNTHESIS AND IN-VITRO STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL SERIES OF NONPEPTIDE ENDOTHELIN ANTAGONISTS
    QUIN, J
    KALTENBRONN, JS
    REISDORPH, BR
    KLUTCHKO, SR
    REYNOLDS, EE
    WELCH, KM
    FLYNN, MA
    DOHERTY, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 157 - MEDI
  • [25] Nonpeptide endothelin receptor antagonists attenuate the pressor effect of diaspirin-crosslinked hemoglobin in rat
    Rioux, F
    Harvey, N
    Moisan, S
    Larivière, R
    Lebel, M
    Grose, JH
    Burhop, K
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1999, 77 (03) : 188 - 194
  • [26] Endothelin Antagonists in Clinical Trials: Lessons Learned
    Barton, Matthias
    Kohan, Donald E.
    ENDOTHELIN IN RENAL PHYSIOLOGY AND DISEASE, 2011, 172 : 255 - 260
  • [27] Endothelin receptor antagonists in cardiology clinical trials
    Neunteufl, T
    Berger, R
    Pacher, R
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (03) : 431 - 443
  • [28] Blocking of the endothelin system: The development of receptor antagonists
    Battistini, B
    Dussault, P
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1998, 11 (2-3) : 97 - 112
  • [29] ENDOTHELIN RECEPTOR ANTAGONISTS - ACTIONS AND RATIONALE FOR THEIR DEVELOPMENT
    WARNER, TD
    BATTISTINI, B
    DOHERTY, AM
    CORDER, R
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (04) : 625 - 635
  • [30] Recent discovery and development of endothelin receptor antagonists
    Wu, CD
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (11) : 1653 - 1668